Bio Special BioInvest
Q4'22 consolidated revenue of KRW 965.5 billion and Q4'22 operating profit of KRW 312.8 billion. FY'22 consolidated revenue of&nb...
January 27, 2023 | News
The proceeds will be used for general corporate purposes, helping Metabolon further accelerate commercialization activities and continue advancing its well...
January 25, 2023 | News
On 9 January 2023, AstraZeneca announced that it had entered into a definitive agreement to acquire CinCor. Following the successful closing of the tender ...
January 23, 2023 | News
Irish company Renew Pharmaceuticals Limited (Renew) led an A$8 million capital raise, with a further A$3 million secured via an Au...
January 23, 2023 | News
Adds Deuruxolitinib, a Potential Best-in-Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, an Autoimmune Dermatological Disease Leverage...
January 20, 2023 | News
Qritive (www.qritive.com), a leading healthcare AI startup has announced that they have raised $7.5M in a funding round led by MassMutual Ve...
January 19, 2023 | News
The Biotechnology Innovation Organization (BIO) will hold its CEO & Investor Conference February 6-9, 2023 to bring biotech companies togethe...
January 18, 2023 | News
"We are excited to have the support of Urban Innovation Fund, Singtel Innov8, and Cercano Management in our mission to bring AI to healthcare," said Pelu T...
January 13, 2023 | News
GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, today announced preliminary unaudited revenue results for the fourth quarter and full ...
January 10, 2023 | News
For the fourth quarter 2022, estimated revenues are anticipated to increase in the low-single digit percent range year-over-year. The Company expects estim...
January 10, 2023 | News
Qritive (www.qritive.com), a leading healthcare AI startup has announced that they have raised $7.5M in a funding round led by MassMutual Ventures, support...
January 09, 2023 | News
Under the terms of the Rights Offering, Parnell is extending the expiration date to Wednesday, January 11, 2023 at 5:00 PM (Eastern Time)&nb...
January 09, 2023 | News
BioVersys AG, a privately held clinical stage, multi-asset Swiss pharmaceutical company focusing on research and development of therapies for life-th...
January 06, 2023 | News
The Notes are currently being offered and sold only to persons who are reasonably qualified institutional purchasers within the meaning of Rule 144A under ...
December 19, 2022 | News
Most Read
Bio Jobs
News